Adaptive Biotechnologies Corp ADPT:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 02/03/23 EST
9.85UNCH (UNCH)
Volume
18,651
Close
9.85UNCH (UNCH)
Volume
970,593
52 week range
5.95 - 17.79
Loading...
  • Open9.49
  • Day High9.93
  • Day Low9.40
  • Prev Close9.85
  • 52 Week High17.79
  • 52 Week High Date02/10/22
  • 52 Week Low5.95
  • 52 Week Low Date06/14/22

Key Stats

  • Market Cap1.409B
  • Shares Out143.01M
  • 10 Day Average Volume0.94M
  • Dividend-
  • Dividend Yield-
  • Beta1.15
  • YTD % Change28.93

KEY STATS

  • Open9.49
  • Day High9.93
  • Day Low9.40
  • Prev Close9.85
  • 52 Week High17.79
  • 52 Week High Date02/10/22
  • 52 Week Low5.95
  • 52 Week Low Date06/14/22
  • Market Cap1.409B
  • Shares Out143.01M
  • 10 Day Average Volume0.94M
  • Dividend-
  • Dividend Yield-
  • Beta1.15
  • YTD % Change28.93

RATIOS/PROFITABILITY

  • EPS (TTM)-1.56
  • P/E (TTM)-6.31
  • Fwd P/E (NTM)-6.86
  • EBITDA (TTM)-199.827M
  • ROE (TTM)-38.88%
  • Revenue (TTM)168.04M
  • Gross Margin (TTM)66.87%
  • Net Margin (TTM)-131.85%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date02/14/2023
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Adaptive Biotechnologies Corp

 

Profile

MORE
Adaptive Biotechnologies Corporation is a commercial-stage company. The Company is focused on using the biology of the adaptive immune system to develop the diagnosis and treatment of disease. Its immune medicine platform combines a suite of chemistry, biology and machine learning to generate clinical immunomics data to decode the adaptive immune system. Its commercial research products include immunoSEQ and immunoSEQ T-MAP. immunoSEQ utilizes bias-controlled polymerase chain...
Chad Robins
Chairman of the Board, Chief Executive Officer, Co-Founder
Julie Rubinstein
President
Mark Adams Ph.D.
Chief Operating Officer
Tycho Peterson
Chief Financial Officer
Address
1165 Eastlake Ave E
Seattle, WA
98109
United States

Top Peers

SYMBOLLASTCHG%CHG
VCEL
Vericel Corp
31.06-0.28-0.89%
BBIO
BridgeBio Pharma Inc
10.86-0.26-2.34%
DCPH
Deciphera Pharmaceuticals Inc
17.03-0.52-2.96%
CPRX
Catalyst Pharmaceuticals Inc
16.10+0.30+1.90%
KNSA
Kiniksa Pharmaceuticals Ltd
14.10-0.07-0.49%